Clearmind Medicine
Treatments for Binge Behavior and Mental Health
StartupClearmind Medicine is a Tel Aviv-Yafo-based startup in the Health Tech & Life Sciences sector, established in 2021. Treatments for Binge Behavior and Mental Health. The company has raised a total of $15.65M across 5 funding rounds, currently at the Public stage. Key investors include Undisclosed Investor(s). The company has 1-10 employees. Core technologies: Biologicals, Molecules.
With $15.65M in total funding, Clearmind Medicine is a Public-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StagePublic
- ProductClinical Trial
- ModelB2B
- Employees1-10
- HQTel Aviv-Yafo
- Last Round$2.4M
- Undisclosed Investor(s)
148 articles covered by sources including finance.yahoo.com,
newsdirect.com,
www.globenewswire.com.
What does Clearmind Medicine do?
Clearmind Medicine develops treatments for binge behavior and mental health, including alcohol use disorder, binge eating and depression. Clearmind develops MEAI that exerts a euphoric alcohol-like experience and a reduced desire to consume alcoholic beverages with potential to change the lives of millions who struggle to drink in moderation.
How much funding has Clearmind Medicine raised?
Clearmind Medicine has raised $15.65M in total funding across 5 rounds. The company is currently at the Public stage. Key investors include Undisclosed Investor(s).
What sector is Clearmind Medicine in?
Clearmind Medicine operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Molecules. Target customers: Healthcare & Life Sciences, Healthcare, Laboratories.
Where is Clearmind Medicine located?
Clearmind Medicine is based in Raoul Wallenberg St 20, Tel Aviv-Yafo, Israel. The company also has offices abroad.